Harnessing AI Across the Drug Discovery Pipeline

The AI in Drug Discovery Stage discusses how leading biopharma companies are applying AI across target discovery, protein design and translational research as well as the latest advances in foundation models, agentic AI,  how AI is accelerating target ID, functional genomics and evidence generation. Sessions will also explore how companies about how they are moving from beyond proof-of-concept studies to deploying AI at scale, with measuring scientific and commercial impact. 

We also have a range of activities for people interested in AI, please see here for more information.

Loading
11:30
  1. Relation's AI & Deep Learning Platform: What datasets the ML models are trained on
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Jake Taylor-King
    Jake Taylor-King, Chief Innovation Officer, Relation Therapeutics
12:00
  1. Sponsored by Bioptimus. More details to be announced shortly.
    AI In Drug Discovery Stage
    30 mins
12:30
  1. Leveraging Genomic Sequence-to-Function Language Models for the Design of Antisense Oligonucleotides
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Majd Saleh
    Majd Saleh, Senior Data Scientist, Servier Institute of Therapeutic Innovation
13:00
  1. Lunch and Networking
    AI In Drug Discovery Stage
    90 mins
14:30
  1. Protein AI Models for Drug Discovery
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Aleix Lafita
    Aleix Lafita, Associate Director, Translational Sciences, GSK
15:00
  1. Sponsored by Rancho. More details to be announced shortly.
    AI In Drug Discovery Stage
    30 mins
15:30
  1. Applying AI for Oncology Drug Target Identification & Prioritisation
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Slavica Dimitrieva
    Slavica Dimitrieva, Associate Director, Oncology Data Science, Novartis
16:00
  1. Networking Break
    AI In Drug Discovery Stage
    30 mins
16:30
  1. The AI Revolution After the Genome: How AI Is Inventing Genetically Enabled Medicines
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Lennard Lee
    Lennard Lee, Chief Medical Officer, The University of Oxford
17:00
  1. Sponsored slot available
    AI In Drug Discovery Stage
    30 mins
17:30
  1. From Human IN the Loop to Human ON the Loop
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Alex Koers
    Alex Koers, Associate Director, Bioscience, AstraZeneca
11:30
  1. Panel Discussion: Are We Seeing Real Breakthroughs from AI, or Just Faster Trial and Error?
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Adam Cribbs
    Adam Cribbs, Co-Founder & CTO, Entelo Bio
    Speaker image for Elisabetta Leo
    Elisabetta Leo, Senior Director, Early Development Asset Lead, Ipsen
    Speaker image for Alireza Moayyeri
    Alireza Moayyeri, Senior Director RWE, UCB
    Speaker image for Caroline Weis
    Caroline Weis, Director, AI for Science, GSK
    Speaker image for Harpreet Saini
    Harpreet Saini, Senior Director, Bioinformatics, Astex Pharmaceuticals 
12:00
  1. Sponsored by Illumina. More details to be announed shortly
    AI In Drug Discovery Stage
    30 mins
12:30
  1. More details to be announced shortly
    AI In Drug Discovery Stage
    30 mins
13:00
  1. Lunch and Networking
    AI In Drug Discovery Stage
    70 mins
14:10
  1. AI-Ready Data Products & Agentic AI for Scientific Workflows
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Elif Ozkirimli
    Elif Ozkirimli, Head of Computational Science Products, Roche
14:40
  1. Sponsored slot available
    AI In Drug Discovery Stage
    30 mins
15:10
  1. Teaching AI to Understand Biology: From Cellular Perturbations to Intelligent Drug Discovery
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Marc Boubnovski Martell
    Marc Boubnovski Martell, Machine Learning Researcher, Novo Nordisk
15:40
  1. Networking Break
    AI In Drug Discovery Stage
    30 mins
16:10
  1. Synthetic Data in Clinical Development: Enabling the Next Generation of Scientific Evidence
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Helena Andres Terre
    Helena Andres Terre, Associate Director, AI & Advanced Analytics, UCB
16:40
  1. Multimodal Identification of Disease Segments
    AI In Drug Discovery Stage
    30 mins
    Speaker(s)
    Speaker image for Holger Klein
    Holger Klein, Senior Principal Scientist Computational Innovation, Boehringer Ingelheim